Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/19/1996 | WO1996040240A1 Helper virus-free aav production |
12/19/1996 | WO1996040231A1 Method for obtaining receptor agonist antibodies |
12/19/1996 | WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | WO1996040205A1 Metabolic effects of certain glutathione analogs |
12/19/1996 | WO1996040199A1 Methods of inhibiting phagocytosis |
12/19/1996 | WO1996040178A1 Use of co-localized islets and sertoli cells in xenograft cellular transplants |
12/19/1996 | WO1996040175A1 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
12/19/1996 | WO1996040172A1 Compositions and methods for improving autologous fat grafting |
12/19/1996 | WO1996040082A2 Apparatus and method for delivering a biologically active compound into a biological environment |
12/19/1996 | WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
12/19/1996 | WO1996039843A1 Controlling hemipteran insect pests with bacillus thuringiensis |
12/19/1996 | WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication |
12/19/1996 | WO1996039812A2 Cryopreservation of diverse plant cells |
12/19/1996 | WO1996039802A1 Hypersensitive response induced resistance in plants |
12/19/1996 | DE19521938A1 Use of compsns. contg. cyclic lipo-peptide(s) as anti-mycotic(s) |
12/19/1996 | CA2288401A1 Icam-4 materials and methods |
12/19/1996 | CA2226463A1 Recombinational cloning using engineered recombination sites |
12/19/1996 | CA2224226A1 Immunoprotective barrier for transplantation of cells |
12/19/1996 | CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses |
12/19/1996 | CA2224174A1 Method for obtaining receptor agonist antibodies |
12/19/1996 | CA2224114A1 Synthetic mammalian chromosome and methods for construction |
12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
12/19/1996 | CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens |
12/19/1996 | CA2224071A1 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
12/19/1996 | CA2224012A1 Developmentally-regulated endothelial cell locus-1 |
12/19/1996 | CA2223959A1 Cryopreservation of diverse plant cells |
12/19/1996 | CA2223932A1 Injectable hydrogel compositions |
12/19/1996 | CA2223891A1 Treatment of insulin resistance |
12/19/1996 | CA2223878A1 Inhibitors of phospholipase a2 |
12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | CA2223493A1 Recombinant viral nucleic acids |
12/19/1996 | CA2223459A1 Regulatory elements conferring tapetum specificity |
12/19/1996 | CA2223440A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons) |
12/19/1996 | CA2223246A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | CA2223181A1 Adenosine kinase polynucleotides |
12/19/1996 | CA2223101A1 Standardized, primary osteoblast cell cultures from osteoporotic patients and their use in the diagnosis of osteoporosis and in testing potential osteoporosis therapeutic agents |
12/19/1996 | CA2223086A1 Novel serpin derived from human hypothalamus |
12/19/1996 | CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | CA2222941A1 A cytotoxicity-based genetic selection system (toxsel) |
12/19/1996 | CA2222793A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | CA2222538A1 Apparatus and method for delivering a biologically active compound into a biological environment |
12/19/1996 | CA2222534A1 In vitro packaging of adeno-associated virus dna |
12/19/1996 | CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | CA2222134A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | CA2221747A1 Cotton fiber transcriptional factors |
12/19/1996 | CA2221726A1 Use of ovary-tissue transcriptional factors |
12/19/1996 | CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | CA2221602A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | CA2221240A1 Controlling hemipteran insect pests with bacillus thuringiensis |
12/19/1996 | CA2220952A1 Anti-allergy bispecific molecules |
12/19/1996 | CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | CA2218896A1 Bile duct progenitor cells and methods of use |
12/19/1996 | CA2196691A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | CA2195767A1 Dual fiber bioreactor |
12/18/1996 | EP0748870A2 Oncostatin M induced hematopoiesis |
12/18/1996 | EP0748869A1 Ectoine synthetase gene |
12/18/1996 | EP0748816A1 Toxoplasma gondii antigen, its production and use |
12/18/1996 | EP0748815A1 Toxoplasma gondii antigen, its production and use |
12/18/1996 | EP0748631A2 Viral vaccines |
12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
12/18/1996 | EP0748376A1 Rna editing enzyme and methods of use thereof |
12/18/1996 | EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
12/18/1996 | EP0618802A4 Synthetic compounds and compositions with enhanced cell binding. |
12/18/1996 | EP0529083B1 Process for producing taxol by cell culture of taxus species |
12/18/1996 | EP0504371B1 Hiv diagnostic method and reagent |
12/18/1996 | CN1138295A A novel tumor suppressor gene |
12/17/1996 | US5585545 Endo-1,4-β-glucanase genes and their use in plants |
12/17/1996 | US5585544 Method of causing somatic hybridization between two species of algae |
12/17/1996 | US5585474 DNA encoding protein possessing metastasis-inhibitory activity |
12/17/1996 | US5585464 Recombinant antigen for diagnosing rheumatoid arthritis |
12/17/1996 | US5585400 Administering conjugated linoleic acid |
12/17/1996 | US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy |
12/17/1996 | US5585351 T-cadherin adhesion molecule |
12/17/1996 | US5585345 CTP extended form of glycoprotein hormones |
12/17/1996 | US5585271 Yeast agglutination genes and yeast containing them |
12/17/1996 | US5585267 Hemidesmosome formation-inducing protein coated on appliance |
12/17/1996 | US5585265 Transforming cells by using viral vectors, then culturing and recovering, genetic engineering |
12/17/1996 | US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus |
12/17/1996 | US5585250 Hiv-1 vaccine; variations and modifications of the v3 loop including additional glycosylation signals |
12/17/1996 | US5585237 Stable genetically engineered cells containing transfected dna sequences which code for viral transcription promoters and activators |
12/17/1996 | US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova |
12/17/1996 | US5585183 Preparation of liquid-core microcapsules for cell cultures |
12/17/1996 | US5585089 Humanized immunoglobulins |
12/17/1996 | CA2006684C Monoclonal antibody against protein c |
12/17/1996 | CA1338800C Hepatitis delta and diagnostics and vaccines |
12/16/1996 | WO1996039508A1 Fibroblast growth factor 13 |
12/12/1996 | WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
12/12/1996 | WO1996039628A1 GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS |
12/12/1996 | WO1996039542A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
12/12/1996 | WO1996039541A1 Colon specific gene and protein |
12/12/1996 | WO1996039540A1 Novel gene-up regulated in regenerating liver |
12/12/1996 | WO1996039530A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
12/12/1996 | WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | WO1996039521A1 Human chemokine beta-13 |
12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |